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Purpose: To determine the impact of incubation solution composition on protein deposition to silicone hydrogel (SH)
contact lenses using a simplistic and a complex model of the tear film.
Methods: Three SH materials – senofilcon A (SA), lotrafilcon B (LB), and balafilcon A (BA) – were incubated in two
different solutions; Solution A was a simplistic augmented buffered saline solution containing a single protein, whereas
Solution B was a complex artificial tear solution (ATS), containing the augmented buffered saline solution in addition to
proteins, lipids, and mucins (pH=7.4). The proteins of interest (lysozyme, lactoferrin, albumin) were radiolabeled with
Iodine-125 (2% protein of interest) and the accumulation of the conjugated protein to the lens materials was determined
after 1, 7, 14, and 28 days of incubation. Protein deposition was measured using a gamma counter and the raw data were
translated into absolute amounts (µg/lens) via extrapolation from standards.
Results: After 28 days, lysozyme uptake was significantly lower on BA lenses when incubated in Solution A (33.7 μg)
compared to Solution B (56.2 μg), p<0.001. SA lenses deposited similar amounts of lysozyme when incubated in either
Solution A (2.6 μg) or Solution B (4.1 μg), p>0.05. LB lenses also deposited similar amounts of lysozyme for both solutions
(Solution A: 5.0 μg, Solution B: 4.7 μg, p>0.05). After 28 days, BA lenses accumulated approximately twice the amount
of lactoferrin than the other lens materials, with 30.3 μg depositing when exposed to Solution A and 22.0 μg with Solution
B. The difference between the two solutions was statistically significant (p<0.001). LB materials deposited significantly
greater amounts of lactoferrin when incubated in Solution A (16.6 μg) compared to Solution B (10.3 μg), p<0.001. Similar
amounts of lactoferrin were accumulated onto SA lenses regardless of incubation solution composition (Solution A: 8.2
μg, Solution B: 11.2 μg, p>0.05). After 28 days, albumin deposition onto BA lenses was significantly greater when lenses
were incubated in Solution B (1.7 μg) compared to Solution A (0.9 μg), p<0.001. Similar amounts of albumin were
deposited on SA lenses when incubated in either solution (0.6 μg versus 0.7 μg, p>0.05). LB lenses incubated in Solution
A deposited more albumin compared to Solution B (0.9 μg versus 0.6 μg), p=0.003.
Discussion: Protein deposition onto SH materials varied when contact lenses were incubated in either a complex ATS
compared to a single protein solution. More lysozyme accumulated onto BA lenses incubated in a complex analog of the
human tear film, whereas lactoferrin deposited onto SA lenses independent of incubation solution composition. To better
mimic the ex vivo environment, future studies should use more appropriate analogs of the tear film.
Silicone  hydrogel  (SH)  lenses  became  increasingly
popular over the last decade primarily due to their higher
oxygen  permeability,  leading  to  reduced  hypoxic
complications  compared  to  poly-2-hydroxyethyl
methacrylate (pHEMA)-based lenses [1,2]. A recent survey
indicated that 54% of all contact lens wearers in the United
States (US) were fitted with SH materials for daily wear, as
compared with only 15% using hydrogel lenses [3]. This has
changed  greatly  since  2005,  where  only  22%  of  the  lens
wearers in the US were fitted with SH lenses [4].
Contact  lenses  are  prone  to  protein  deposition,  the
amounts of which are dependent on the chemical composition
of the lens materials [5,6]. Several studies have shown that
deposition onto contact lenses may cause discomfort [7] acute
red  eye  [8],  and  inflammatory  reactions  [9].  Deposited
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proteins  denature  over  time  and  hence  may  cause
inflammatory responses to the palpebral conjunctiva, such as
giant papillary conjunctivitis [10]. Contact lens wear can lead
to  microbial  keratitis  through  infection  of  the  cornea  by
pathogenic organisms, such as gram-negative Pseudomonas
aeruginosa, which adhere to the protein-coated lens material
[11].  Tear  film  deposits  may  further  reduce  visual  acuity
[12] and surface wettability [13].
Several different tear film proteins have been detected in
the  proteomic  profiles  deposited  on  SH  contact  lenses,
including albumin, lipocalin, lactoferrin, and lysozyme [14,
15]. Many other proteins have further been extracted from
worn  contact  lenses,  some  examples  are  complement  C3
[16], immunoglobulin E (IgE) [17], immunoglobulin G (IgG)
[18], and secretory phospholipase A2 [19]. Using antibody
arrays, several chemokines, cytokines, and growth factors
have been detected in the human tear film [20], as well as
proteases  and  protease  inhibitors  detected  through  mass
spectrometers [21]. There are more than 100 different proteins
identified  in  the  tear  film  [21,22],  constituting  a  protein
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337concentration  of  around  8  mg/ml  [21,23].  Lysozyme  is
primarily used as the “model protein” for in vitro studies
investigating deposition on lenses. The main reasons for this
are the high abundance of this positively charged protein in
the tear film and the fact that it accounts for approximately
90% of the deposited protein on ionic (negatively charged)
pHEMA-based lenses [16,24].
Most SH contact lenses available today are non-ionic and
deposit  substantially  less  protein  than  ionic  conventional
hydrogels [25]. Deposition profiles are often determined using
simplified  in  vitro  models,  however,  there  are  several
differences  between  in  vitro  and  ex  vivo  results  when
comparing  protein  accumulation  on  contact  lenses  [14,
26-28].  The  in  vitro  model  typically  lacks  the  effect  of
blinking,  surface  drying,  the  cleansing  process  of  contact
lenses between hours of wear, and the physiologic events that
are naturally occurring in the eye. As a result, the level of
lysozyme deposition determined on ionic pHEMA lenses is
typically  slightly  lower  on  worn  lenses  compared  to  data
collected on in vitro deposited lenses (ex vivo=985–991 μg of
lysozyme [26,29], in vitro=1,434–1,800 μg of lysozyme [27,
30,31]). In comparison to pHEMA, SH lenses deposit much
lower amounts of lysozyme, averaging <20 μg/lens [26,32].
SH  materials  generally  accumulate  similar  amounts  of
protein, except for the ionic SH material balafilcon A (BA),
which deposits much great amounts of protein per lens [5,
30]. Subbaraman and colleagues illustrated in an in vitro study
that senofilcon A (SA) and lotrafilcon B (LB) lenses deposited
3.7 μg and 6.1 μg of lysozyme, whereas BA deposited more
than three times that amount (19.4 μg) after two weeks of
incubation [30]. Ex vivo data from Subbaraman et al. [33]
have further shown that after two weeks of lens-wear, SA and
LB deposit similar amounts of total protein - 4.6 μg and
6.6 μg, respectively, - whereas BA deposits 26.9 μg, which is
only marginally higher compared to the lysozyme in vitro
results. Zhao and colleagues demonstrated a similar pattern,
where BA lenses deposited the greatest amount of protein and
SA the least; however, SA lenses deposited significantly less
protein  (0.1  μg  [5])  than  findings  by  Subbaraman  and
colleagues (4.6 μg [33] ).
In vitro deposition studies have limitations when single
protein solutions are used, as they cannot accurately mimic
the  ocular  tear  film,  due  to  their  lack  of  other  tear  film
components,  including  other  proteins,  lipids  and  mucins
[30]. The use of more complex artificial tear solutions (ATS)
on pHEMA-based contact lenses has shown to impact lipid
and lysozyme uptake onto the lens material [34-36]. Whether
proteins that are different in size and charge respond in a
similar fashion when depositing to SH lenses is not clear,
therefore the purpose of this in vitro study was to compare the
amount of protein uptake on different SH lens materials using
two  different  in  vitro  models.  The  first  model  uses  an
augmented  buffered  saline  solution  with  a  single  protein
added, whereas the second model uses a far more complex
ATS, consisting of the augmented buffered saline solution as
its base, for lens incubation.
METHODS
A single protein solution and a complex ATS were used to
investigate potential differences in protein deposition to SH
materials,  using  radiolabeled  lysozyme,  lactoferrin  and
albumin.
Three SH contact lens materials were investigated in this
study,  senofilcon  A  (SA,  ACUVUE  OASYS;  Johnson  &
Johnson,  Jacksonville,  FL),  lotrafilcon  B  (LB,  Air  Optix;
CIBA  VISION,  Duluth,  GA),  and  balafilcon  A  (BA,
PureVision; Bausch & Lomb, Rochester, NY). These lenses
have  been  categorized  in  different  Food  and  Drug
Administration  (FDA)  groups,  with  both  SA  and  LB
belonging to FDA group I (low water content <50%, non-
ionic), whereas BA belongs to FDA group III (low water
content <50%, ionic).
Two independent studies were performed in parallel to
investigate the deposition of a single protein when added to a
saline solution compared to a complex ATS (Figure 1). To
identify the protein of interest in the solution and on the lens,
proteins  were  conjugated  with  Iodine-125  (125I).  The
conjugated proteins included hen egg lysozyme (HEL) bovine
colostrum  and  milk  lactoferrin  (BCL/BML),  and  bovine
serum  albumin  (BSA).  The  iodine  monochloride  method
[37,38] was used to radiolabel the proteins of interest, by
covalently  binding  125I  to  the  tyrosine  ring  [39,40].  The
radiolabeled proteins were added to the incubation solutions
at  a  concentration  of  2%  of  the  individual  protein
concentration. Control solutions not containing a contact lens
were used to verify radioactivity in the solution and decay over
time.
Single protein solution: The single protein solution (A)
consisted of an augmented buffered saline solution containing
different salts, glucose, and urea (Table 1). This was adapted
from Van Haeringen [41] and further modified at the Centre
for Contact Lens Research [42]. A single protein of interest
was added to the solution.
The saline solution was prepared with Milli-Q water in a
glass  beaker  using  a  stir  bar  for  constant  mixing.  The
individual components were added to the solution. Finally,
ProClin-300  (200 μl/l solution; Sigma, Oakville, ON), an
antimicrobial  agent,  was  added  to  the  solution  to  inhibit
bacterial growth. If necessary, NaOH was used to adjust the
solution to a physiologic pH of 7.4 [43]. The pH was further
determined at each study time point using pH paper (VWR,
Mississauga, ON) to verify an unchanged environment of the
solution at a pH of about 7 on a scale of 1–12.
The solution was split into three batches and one protein,
either HEL (1.9 mg/ml), BCL/BML (1.9 mg/ml), or BSA
(0.5 mg/ml) was added to make Solution A.
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338Complex ATS: The complex ATS (B) consisted of the
saline  solution  described  above,  plus  proteins,  lipids  and
mucins (Table 2). All lipids and proteins were purchased from
Sigma-Aldrich.
The concentration of cholesterol was adapted through a
formulation  from  a  couple  of  studies.  Haberland  and
colleagues [50] state in a study that the maximum solubility
of  cholesterol  in  aqueous  solution  is  0.0018  mg/ml.
Interestingly,  Saatci  and  colleagues  [51]  state  that  the
concentration of cholesterol found in the tear film is greater.
The IgG concentration was adapted from several literature
values [45-47]. Coyle and Sibony [47] provide a range of IgG
concentration found in the tear film that better relates to this
study.
The saline solution was prepared as described above and
all proteins were added (Table 2). Concentrated lipids were
mixed in a separate flask with hexane-ether and sonicated for
5 min to break down the lipids into micelles. The lipid and
protein solution were combined and nitrogen purged with
nitrogen for 10 min to adjust the pH and evaporate hexane-
ether.
Contact lens incubation: All lenses were individually
soaked in 5 ml of the prepared saline for 24 h, to remove any
packaging solution components from the lenses. The lenses
Figure 1. Flowchart depicting layout of
two-part study, where each time point
contained three replicates.
TABLE 1. COMPONENTS OF THE SALINE SOLUTION.
Component mM (mmol/ml) MW (g/mol)
C6H12O6* 0.2 180.2
CaCl2* 0.5 147
H2O - -
HCl (10 M)* - -
KCl# 16 74.55
KHCO* 3 100.12
Na2CO3+ 12 105.99
Na2HPO4* 24 141.96
Na3C6H5O7^ 1.5 294.1
NaCl* 90 58.44
(NH2)2CO! 1.2 60.06
ProClin 300* - -
C6H12O6 (glucose), CaCl2 (calcium chloride), H2O (Milli-Q gradient), HCl (10 M, hydrochloric acid), KCl (potassium chloride),
KHCO3 (potassium bicarbonate), Na2CO3 (sodium carbonate), Na2HPO4 (sodium hydrogen phosphate), Na3C6H5O7 (trisodium
citrate), NaCl (sodium chloride), (NH2)2CO (urea). * Sigma-Aldrich, Oakville, ON, # BDH Inc., Toronto, ON, + EMD Chemicals
Inc., Gibbstown, NJ, ^ Caledon Laboratories LTD., Georgetown, ON, ! EM Science, Gibbstown, NJ.
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339were  handled  with  silicone-tipped  tweezers  in  a  sterile
environment.  Screw-capped  glass  vials  (6  ml;  VWR,
Mississauga, ON) were autoclaved and pre-treated for 4–7
days with the same solution used for lens incubation, to coat
the vials and minimize adsorption of elements to the walls of
the vials during the lens incubation. During the pre-treatment
phase, the concentration of lactoferrin (1.8 mg/ml) was halved
to 0.9 mg/ml due to quantity and cost limitations. For similar
reasons, both IgG and lactoferrin were omitted when pre-
treating the complex ATS vials.
To fully submerge the lens, each lens was incubated in
1.5 ml of solution at 37 °C and placed on a rotatory shaker at
60 rpm (VWR). Time periods of 1, 7, 14, and 28 days were
investigated  using  three  replicates  per  lens  type  and  time
point, resulting in a total of 216 contact lenses being examined
in the study.
After each incubation period, lenses were removed from
the incubation solution, rinsed in saline twice, placed in a
12×75 mm culture tube (VWR), air-dried for 12 h to allow
evaporation  of  unbound  iodine.  The  Wallac  Wizard  1470
Gamma Counter (Perkin Elmer, Woodbridge, ON) was used
to quantify the amount of protein deposited on the lens.
RESULTS
This  study  consisted  of  two  experiments,  undertaken  in
parallel, to compare the deposition of lysozyme, lactoferrin
and albumin to SH materials, when incubated in a single
protein versus a complex ATS solution.
The pH of both solutions used for incubation (Solutions
A and B) was checked at each time point. The results were in
good agreement with the human tear film, which has a pH of
approximately 7.4 [43]. Control solutions, not containing a
contact  lens,  confirmed  the  anticipated  amount  of
radioactivity in each solution, permitted us to monitor the
radioactive decay over time and protein quantification.
Data analysis was conducted using Statistica 9 (StatSoft
Inc. Tulsa, OK). A repeated measures ANOVA was used to
compare protein deposition on the different lens materials
over time. Factors included in the ANOVA were: protein of
interest, contact lens material, and time point. Tukey’s HSD
(Honestly Significant Difference) test was used for post-hoc
comparisons; p<0.05 was considered significant.
Lysozyme—Results are presented in Figure 2. All lens
types showed an increase in lysozyme deposition between
days 1 and 28, independent of solution used for incubation
(p<0.001).
After 1 day of incubation, SA lenses accumulated similar
amounts  of  lysozyme  when  incubated  in  either  solution
(Solution  A:  0.28±0.03  μg,  Solution  B:  0.31±0.03  μg;
p=1.00). Slightly more lysozyme was found after 28 days: SA
lenses accumulated 4.06±0.19 μg when incubated in Solution
B and 2.57±1.33 μg using Solution A, however, this difference
was  also  not  statistically  significant  (p=0.20).  LB  lenses
deposited similar amounts of lysozyme with both solutions
(Solution  A:  0.74±0.08  μg,  Solution  B:  (0.58±0.09  μg);
p=1.00) after 1 day of incubation. This amount increased after
28 days to 4.99±0.01 μg and 4.70±0.20 μg using Solution A
and  B,  respectively  (p=1.00).  BA  accumulated  similar
amounts of lysozyme after 1 day (Solution A: 4.69±0.19 μg,
Solution B: 4.96±0.19 μg; p=1.00) independent of the solution
used, but deposited significantly higher amounts after 14 and
28 days when incubated in Solution B (Day 28: Solution
A=33.68±1.81  μg;  Solution  B=56.22±1.59  μg;  p<0.001;
Figure 2).
Overall,  lysozyme  deposition  increased  between  each
time point for either solutions (A and B) over a period of 28
days (p<0.001), with Solution B depositing significantly more
lysozyme than Solution A by day 28 (p<0.001). Independent
of lens type, lysozyme deposition increased from day 1 to 28,
depositing significantly greater amounts of protein between
each time point, for both Solutions A and B (p<0.001).
Lactoferrin—Results are presented in Figure 3. From
day 1 to 28, the amount of lactoferrin deposition for each lens
type increased independent of solution used for incubation
(p<0.001).
After 1 day of incubation, SA lenses accumulated similar
amounts of lactoferrin using Solution A (0.81±0.09 μg) and
Solution B (0.81±0.04 μg; p=1.00). After 28 days, slightly less
lactoferrin  was  seen  when  incubated  in  Solution  A
(8.17±0.70 μg) in comparison to Solution B (11.21±0.28 μg;
p=0.17). LB lenses incubated in Solution A (5.34±0.17 μg)
accumulated  slightly  more  lactoferrin  than  Solution  B
(2.16±0.07 μg) after 1 day, however this difference was not
significant (p=0.13). After 28 days however, LB deposited
significantly more lactoferrin when incubated in Solution A
TABLE 2. COMPONENTS OF THE COMPLEX ARTIFICIAL TEAR SOLUTION.
Lipids C (mg/ml) Proteins C (mg/ml)
Cholesterol [34-36] 0.0018 Albumin [44] 0.5
Cholesteryl oleate [34] 0.024 IgG [45-47] 0.02
Oleic acid [35,36] 0.0018 Lactoferrin [34,36] 1.8
Oleic acid methyl ester [34] 0.012 Lysozyme [34,36] 1.9
Phosphatidyl choline [48,49] 0.0005 Mucin [34,36] 0.15
Triolein [34] 0.016 Saline solution -
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340compared to Solution B (Solution A: 16.62±0.86 μg, Solution
B: 10.28±1.66 μg; p<0.001). BA lenses also attracted slightly
higher amounts of lactoferrin when incubated in Solution A
(5.75±0.86 μg) compared to Solution B (2.62±0.66 μg) after
1 day (p=0.14) which became statistically significant after 28
days, where Solution A allowed for 30.25±2.10 μg of deposits
on  the  lenses  compared  to  Solution  B  (22.04±0.51  μg;
p<0.001; Figure 3).
There was overall an increase in lactoferrin deposition
between days 1 and 28 (p<0.001), with Solution A depositing
significantly  more  lactoferrin  than  Solution  B  (p=0.017).
Independent of lens type, lactoferrin deposits similarly on lens
materials incubated in Solution A at day 1 and 7 (p=0.91).
However, there was an increase in the rate of accumulation
between the other time points (day 7 and 14 [p<0.001]; day
14 and 28 [p=0.001]). With regards to Solution B, there was
not a significant difference between lactoferrin deposits at
days 1 and 7 (p=0.52), 14 and 28 (p=1.00), but a significant
difference between days 7 and 14 (p<0.001).
Albumin—Results are presented in Figure 4. In general,
there was an increase in albumin deposition for each lens type
from day 1 to 28, independent of solution used for incubation
(p<0.001).
After 1 day of incubation, SA lenses accumulated similar
amounts  of  albumin  when  incubated  in  either  solution
(Solution  A:  0.32±0.02  μg,  Solution  B:  0.45±0.02  μg;
p=0.70). A similar result was also seen after 28 days, showing
0.56±0.06  μg  when  incubated  in  Solution  A  and
0.70±0.09  μg  using  Solution  B  (p=0.53).  LB  deposited
significantly  more  albumin  in  Solution  A  (0.66±0.05  μg)
compared  to  Solution  B  (0.40±0.06  μg)  after  1  day  of
incubation  (p=0.04).  Likewise  more  albumin  was
accumulated after 28 days when lenses were incubated in
Solution  A  (0.92±0.03  μg)  compared  to  Solution  B
(0.58±0.08 μg; p=0.003). After 1 day of incubation, BA lenses
deposited similar amounts of albumin with both solutions
(Solution  A  [0.57±0.07  μg];  Solution  B  [0.73±0.03μg;
p=0.38]). With a longer incubation of 28 days, BA lenses
accumulated significantly less (p<0.001) albumin in Solution
A  (0.85±0.00  μg)  in  comparison  to  Solution  B
(1.68±0.04 μg; Figure 4).
Overall,  there  was  an  increase  in  albumin  deposition
between day 1 and day 28 and also between each time point
(p<0.001),  with  Solution  B  depositing  significantly  more
albumin than Solution A (p=0.008). Independent of lens type,
the amount of albumin increased from day 1 to day 7 (p=0.01)
using Solution A and a plateau was seen after this time point
(day 7 and 14 [p=0.18], day 14 and 28 [p=0.40]). With regards
to Solution B, there was a significant difference between each
time point, as protein deposition increased significantly at
each  measurement;  day  1  and  7  (p=0.02),  day  7  and  14
(p<0.001), day 14 and 28 (p<0.001).
Figure  2.  Lysozyme  deposition  to
senofilcon  A,  lotrafilcon  B,  and
balafilcon  A  lenses  using  a  single
protein  solution  and  a  complex  ATS
solution. Incubation time points: 1, 7, 14
and 28 days.
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341DISCUSSION
The human tear film contains a variety of proteins, lipids, and
mucins,  each  of  which  differs  in  size,  charge,  and
concentration [29,52,53]. Positively charged lysozyme [26]
(14.5  kDa  [54])  and  the  iron-binding  protein  lactoferrin
(80 kDa [55]) constitute major proportions of the tear film,
measuring  1.9  mg/ml  [56]  and  1.5–2.2  mg/ml  [55],
respectively. Lysozyme contains three positive binding sites
[57], whereas lactoferrin has one [58]. Albumin, a negatively
charged protein, has a molecular weight of 66 kDa [59] and
is found in the tear film at a concentration ranging from 0.02
to 0.5 mg/ml [60,61].
The contact lens materials investigated in this study were
incubated in a non-competitive, single protein solution and a
complex ATS, consisting of multiple proteins, mucins, and
lipids. This complex ATS, according to the Vroman effect,
will allow for sequential adsorption of proteins to the lens
surface  [52,62,63].  Blood  plasma  proteins  undergo  the
Vroman  effect  when  adsorbing  onto  artificial  surfaces,
particularly the displacement of fibrinogen by other plasma
proteins  [64].  Sariri  and  Sabbaghzadeh  [65]  have
demonstrated competitive protein binding onto soft contact
lens  surfaces  and  the  ability  of  proteins  to  displace  one
another. To-date, only a few studies have determined the
impact of other tear components during the sorption process,
and no data were available on proteins of different charge, size
and abundance and their interaction with SH materials [25,
30]. It was predicted that the negatively charged albumin
would deposit to only a minor extent onto negatively charged
materials, due to electrostatic repulsion [66].
The three SH lenses investigated in this study differed in
material composition, water content and surface modification.
The SA material contains a copolymerization of HEMA and
N,  N-dimethyl  acrylamide  with  (3-methylacryloxy-
2hydroxypropyloxy)  propylbis  (trimethylsiloxy)
methylsilane  [67].  In  addition,  an  internal  wetting  agent
(polyvinyl pyrrolidone (PVP)) is incorporated into SA lenses
to  improve  wettability  [68-70].  Lysozyme  contributes  6–
13 μg of the total protein deposition per SA lens in in vitro
studies [27,30], whereas ex vivo studies report up to 7 μg of
total  protein  per  lens  deposited  [5,28,33],  with  lysozyme
contributing  about  25%  [28,33],  demonstrating  that  more
lysozyme is deposited in vitro (6–13 μg versus 1.75 μg). For
SA lenses, there was no statistically significant difference in
deposition  of  any  of  the  proteins  investigated  whether
Solution  A  or  B  was  used  for  incubation  (p=NS).  This
suggests that this material is unaffected by incubation solution
composition. Given the complex nature of the ATS, this result
suggests that little competition for protein deposition occurs
with this material, and that protein deposition is driven by non-
competitive factors. After 28 days, SA also deposited the
lowest amount of all three proteins, as compared with the other
two materials. This low level of deposition has been seen in
other in vitro and ex vivo studies [27,28,30,33], and may be
Figure  3.  Lactoferrin  deposition  to
senofilcon  A,  lotrafilcon  B,  and
balafilcon  A  lenses  using  a  single
protein  solution  and  a  complex  ATS
solution. Incubation time points: 1, 7, 14
and 28 days.
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342attributed to the neutral surface charge and, specifically, the
presence of PVP, which for both contact lenses and other
biomaterial applications has also been shown to exhibit low
levels of protein deposition [30,71].
The LB material has a co-continuous biphasic- siloxy and
hydrogel phase, which aids the lens in maintaining oxygen
and salt transmission [67]. This lens material is coated by
hydrophilic plasma to improve hydrophilicity of the surface
[67,72] and this plasma coating (25 nm thick) limits access to
the underlying polymer, hence decreasing protein deposition
on this material and within the matrix [6,73]. In vitro studies
on LB show that lysozyme contributes about 6–10 μg of total
protein deposited per lens [25,27]. Ex vivo studies illustrate
that >7 μg [74,75] of total protein per lens is deposited, with
<25% being lysozyme [28,33]. After 28 days of incubation,
no differences in the amounts of lysozyme deposited on LB
lenses were measured between the two incubation solutions
(p=NS). This may be due to the size of lysozyme, which is the
smallest of the three proteins and may outcompete the other
two proteins, appearing as if it is accumulating on the lens
material  without  competition  from  other  proteins.  A
significant  difference  in  both  lactoferrin  and  albumin
accumulation  occurred  (p<0.05),  with  the  simplistic
incubation  solution  (Solution  A)  producing  the  greatest
deposition. These data suggest that when exposed to Solution
A, which has no lysozyme, the other two proteins of interest
can  deposit  freely,  without  the  competitive  binding  that
lysozyme exhibits. After 28 days, in comparison with the other
two materials, LB deposits more protein than SA, but less than
BA.
The  BA  material  has  a  biphasic  character  due  to
copolymerization of the TRIS derivative vinyl carbamate and
N-vinyl pyrrolidone [67]. Hydrophilic glassy silicate ‘islands’
can be seen on the surface of BA lenses [6] due to the oxidation
of TRIS [67]. BA is considered ionic (FDA Group III) due to
its incorporation of N-vinyl aminobutyric acid and as a result,
this  material  typically  accumulates  more  tear  proteins,
particularly those that are positively charged, compared to
other  SH  lenses  [5,27,30].  Furthermore,  unlike  other  SH
lenses, the surface of BA is more porous, allowing for protein
to penetrate through the matrix [72,73]. Of the total amount
of protein depositing on worn BA lenses (5–34 μg) [5,33],
lysozyme accounts for 32% [76] to 50% [25]. Previous in vitro
studies  report  that  lysozyme  deposits  approximately
10-20 μg of protein per lens [30,76]. Lysozyme accumulated
significantly more on BA lenses (p<0.05) when incubated in
the complex ATS. This is an interesting phenomenon, as it
would be predicted that there would be no difference between
the two solutions because of lysozyme’s ability to deposit on
a negatively charged material in large amounts, independent
of incubation solution. One potential explanation could be that
when  exposed  to  a  complex  ATS  that  there  is  an  initial
deposition of the positively charged lysozyme, which acts to
partially neutralize the surface charge of the BA material,
Figure  4.  Albumin  deposition  to
senofilcon  A,  lotrafilcon  B,  and
balafilcon  A  lenses  using  a  single
protein  solution  and  a  complex  ATS
solution. Incubation time points: 1, 7, 14
and 28 days.
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343allowing some binding of the negatively charged albumin,
which then results in a “layering” of proteins on top of this
initial  layer  [77,78].  Lactoferrin,  as  expected,  deposited
significantly more on the BA material when incubated in the
simplistic solution. This is due to the decrease in available
binding sites on the negatively charged BA material, due to
lysozyme’s  competitive  behavior.  In  contrast,  albumin
deposited more when lenses were incubated in the complex
ATS (Solution B). The low level when exposed to Solution A
is expected, as both BA and albumin are negatively charged
and exhibit mutual electrostatic repulsion. The higher level
when exposed to the complex Solution B can be attributed to
the partial neutralization of the BA material by the positively
charged lysozyme and lactoferrin, allowing albumin for an
increased opportunity to bind to the BA surface. Of the three
materials examined, BA deposits the highest amount of all
three proteins.
Patient-worn senofilcon A lenses deposit approximately
7 μg [28,33] of total protein, whereas lenses incubated in
Solution A and B deposited approximately two times more
protein (11.30 μg and 15.97 μg, respectively (sum of 125I data
from all three proteins). Lotrafilcon B lenses in Solution A
deposited  approximately  three  times  more  total  protein
(22.53  μg)  than  what  has  been  found  in  ex  vivo  studies
(>7 μg [14,74,75]), whereas Solution B lenses accumulated
roughly two times more total protein (15.56 μg). Ex vivo
studies on balafilcon A have found 5–34 μg [5,33] of total
protein,  whereas  BA  lenses  incubated  in  Solution  A
accumulated  two  times  more  protein  (64.78  μg)  versus
approximately  three  times  more  total  protein  when  using
Solution B (79.94 μg). Several reasons may account for these
differences. The naturally occurring physiologic events of the
eye, blinking, and surface drying are all lacking in this in vitro
model. The lens surface in vivo dries between blinks as the lid
wipes over the material [79] and this drying is known to
influence deposition onto lens materials from the tear film
[80]. Most importantly, ex vivo studies typically contain the
use of a care regimen each day, which would be predicted to
decrease protein accumulation on the lens material over time.
In  conclusion,  this  study  confirms  that  there  are
differences  in  amounts  of  protein  deposition  onto  SH
materials incubated in either a single protein or complex ATS
incubation  solution.  The  results  showed  that  protein
accumulation was further dependent on incubation time, the
nature of the protein (size, concentration, and charge) and type
of  SH  material.  BA  was  the  greatest  accumulator,  as
previously reported. With regards to lysozyme deposition, no
impact of the type of solution was seen for SA and LB lenses,
however, BA lenses incubated in Solution B deposited greater
amounts of lysozyme. Greater amounts of lactoferrin also
accumulated on LB and BA lenses when incubated in Solution
A, whereas the opposite trend was seen for SA lenses, which
deposited more lactoferrin with Solution B. Finally, BA lenses
deposited  greater  amounts  of  albumin  when  incubated  in
Solution B, whereas LB lenses accumulated more albumin
when incubated in Solution A, while less solution impact was
found using SA lenses.
The diversity of the results in this study highlights the
importance  of  using  appropriate  in  vitro  models,  as  the
outcome for protein accumulation to certain contact lens -
protein interactions is strongly impacted by the competitive
nature of the respective tear film components.
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